An underdeveloped pharma brand, positioned as the only non-addictive treatment for
substance abuse, struggled to gain traction despite its unique benefits. Clinical claims
lacked alignment with how healthcare providers approached addiction treatment, limiting the brand’s potential. Partnering with AiGILE, the team optimized claims using
behavioral heuristics, avoiding the need for new trials.
By addressing key biases like Dread Risk and Zero Risk, AiGILE crafted messaging that
resonated deeply with providers. The result was a transformed brand strategy, 75%
better message performance in research, and an unprecedented 30% CAGR growth
over five years—proving the power of science-driven messaging in healthcare.